Advertisement

Topics

Alvotech provides Stelara biosimilar supply to Fuji Pharma

11:16 EDT 17 Apr 2019 | BioPharma-Reporter

Fuji Pharma signs agreement to receive an exclusive supply of the ustekinumab biosimilar for the Japanese market, furthering a previous investment agreement.

Original Article: Alvotech provides Stelara biosimilar supply to Fuji Pharma

NEXT ARTICLE

More From BioPortfolio on "Alvotech provides Stelara biosimilar supply to Fuji Pharma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...